Walker Family Cancer Centre
Welcome,         Profile    Billing    Logout  
 17 Trials 
19 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ishkanian, Adrian
SABR-COMET-3, NCT03862911: Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer

Recruiting
N/A
330
Europe, Canada, RoW
palliative radiotherapy, Stereotactic ablative radiotherapy
British Columbia Cancer Agency, London Regional Cancer Program, Canada, The Alfred, Beacon Hospital, Ireland, Cancer Trials Ireland, Cancer Research UK Edinburgh Centre, Bon Secours Cork Cancer Centre, UPMC Hillman Cancer Centre, Beatson West of Scotland Cancer Centre, Tom Baker Cancer Centre, Walker Family Cancer Centre, Riverina Cancer Care Centre
Metastatic Tumors
09/30
09/30
Palma, David
SABR-COMET 10, NCT03721341: Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors

Active, not recruiting
3
204
Europe, Canada, RoW
Palliative Radiation, Palliative Radiotherapy, Chemotherapy, Immunotherapy, Hormones, Observation, Stereotactic Ablative Radiotherapy
David Palma, Amsterdam University Medical Centre, VUmc Site, British Columbia Cancer - Centre for the North, Beaston West of Scotland Cancer Centre, London Health Sciences Centre
Metastatic Tumors
01/29
01/29
SABR-SYNC, NCT05717166: A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

Recruiting
3
180
Canada
Palliative Radiotherapy, Chemotherapy, Cytotoxic Systemic Therapy, Hormone therapy, Hormonal Systemic Therapy, Immunotherapy, Targeted Systemic Therapy, Observation, Stereotactic Ablative Radiotherapy, Surgery, Radiofrequency Therapy (RFA), Fractionated Radiation
David Palma
Metastatic Tumor
04/29
04/29
MISSILE, NCT02136355: A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer

Completed
2
40
Canada
Stereotactic Body Radiation Therapy plus Surgery
Lawson Health Research Institute
Non Small Cell Lung Cancer
11/22
11/22
ORATOR, NCT01590355: A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery

Active, not recruiting
2
68
Canada, RoW
Radiotherapy, Transoral Robotic Surgery + Neck Dissection
Lawson Health Research Institute
Early-Stage Squamous Cell Carcinoma of the Oropharynx
09/23
09/23
OPTIMAL HN, NCT04221165: Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer

Completed
2
49
Canada
Opioids, PAiN - multimodal analgesia
Lawson Health Research Institute, Ontario Institute for Cancer Research
Head and Neck Cancer, Radiation-Induced Mucositis
09/23
09/23
SHORT-OPC, NCT04178174: Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Recruiting
2
106
Canada
SABR boost and de-escalated chemoradiation, Standard chemoradiation
Centre hospitalier de l'Université de Montréal (CHUM), M.D. Anderson Cancer Center, Lawson Health Research Institute, Jewish General Hospital
Head and Neck Cancer, Oropharynx Cancer, Human Papilloma Virus
12/24
12/26
VOCAL, NCT03759431: Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer

Recruiting
2
155
Canada, US
Vocal-cord Radiotherapy, Complete Larynx Radiotherapy
Centre hospitalier de l'Université de Montréal (CHUM), London Health Sciences Centre, M.D. Anderson Cancer Center
Cancer Neck, Larynx Cancer, Glottis Tumor
10/24
07/26
SABR-COMET, NCT01446744: Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors

Active, not recruiting
2
99
Europe, Canada, RoW
Stereotactic ablative radiotherapy, palliative radiotherapy
Lawson Health Research Institute, London Regional Cancer Program, Canada, VU University of Amsterdam
Metastatic Tumors
06/26
06/26
RESPIRE-ILD, NCT05986318: Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease

Recruiting
2
98
Canada
N-Acetyl cysteine, NAC, Dexamethasone Oral, Corticosteroid, N-Acetyl cysteine Placebo, NAC Placebo, Dexamethasone Placebo, Corticosteroid Placebo, Radiation Therapy
David Palma, London Health Sciences Centre, Centre Hospitalier de l'Universite de Montreal (CHUM)
Lung Cancer, Interstitial Lung Disease
07/28
12/32
REPAIR, NCT06558175: Reirradiation Dose Escalation in Thoracic Cancers

Not yet recruiting
1
48
NA
stereotactic body radiation therapy (SBRT), Radiation therapy
Lawson Health Research Institute
Thoracic Cancer, Lung Cancer, Esophageal Cancer
10/26
01/27
NCT04852588: Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment

Recruiting
N/A
29
Canada
Endobronchial ultrasound-guided transbronchial fine needle aspiration (EBUS-TFNA), Transesophageal ultrasound-guided fine needle aspiration (EUS-FNA)
Lawson Health Research Institute, Academic Medical Organization of Southwestern Ontario
Non-Small Cell Lung Cancer
05/25
05/25
DART, NCT05233904: Diagnostic-CT-Enabled Planning: A Randomized Trial in Palliative Radiation Therapy

Recruiting
N/A
33
Canada
Diagnostic-CT-enabled Planning, Standard of Care
Lawson Health Research Institute
Advanced Cancer Requiring Palliative Radiation
06/23
08/23
ASPIRE-ILD, NCT03485378: Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease

Active, not recruiting
N/A
39
Europe, Canada
Stereotactic Ablative Radiotherapy
Lawson Health Research Institute, London Health Sciences Centre, University of British Columbia, Western University, Canada
Non Small Cell Lung Cancer, Interstitial Lung Disease
01/22
09/26
NCT05314946: Nutritional Support During Induction Therapy for Esophageal Cancer

Recruiting
N/A
26
Canada
No feeding tube placed, Placement of a percutaneous feeding tube
Mehdi Qiabi
Esophageal Cancer, Nutrition Aspect of Cancer
09/24
12/24
RT-NOW, NCT06156800: Is Radiation-before-pathology a Feasible Approach in the Palliative Oncology Setting? A Pragmatic Clinical Trial

Recruiting
N/A
48
Canada
David Palma
Cancer
05/25
02/26
PET-BOOST, NCT02788461: Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy

Active, not recruiting
N/A
78
Canada
Chemoradiotherapy, Chemoradiotherapy with Integrated Boost Dose
Lawson Health Research Institute
Non-Small Cell Lung Cancer
04/25
04/25
ORATOR2, NCT03210103: Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer

Active, not recruiting
N/A
61
Canada, RoW
Radiation, Chemotherapy, if required, Transoral Surgery (TOS) + Neck Dissection, Radiation, if required
Lawson Health Research Institute
Oropharyngeal Cancer
08/28
08/28
SABR-COMET-3, NCT03862911: Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer

Recruiting
N/A
330
Europe, Canada, RoW
palliative radiotherapy, Stereotactic ablative radiotherapy
British Columbia Cancer Agency, London Regional Cancer Program, Canada, The Alfred, Beacon Hospital, Ireland, Cancer Trials Ireland, Cancer Research UK Edinburgh Centre, Bon Secours Cork Cancer Centre, UPMC Hillman Cancer Centre, Beatson West of Scotland Cancer Centre, Tom Baker Cancer Centre, Walker Family Cancer Centre, Riverina Cancer Care Centre
Metastatic Tumors
09/30
09/30

Download Options